Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

Beijing Hotgen Biotech Revenue

Beijing Hotgen Biotech had revenue of 116.03M CNY in the quarter ending March 31, 2026, with 24.44% growth. This brings the company's revenue in the last twelve months to 427.66M, down -12.17% year-over-year. In the year 2025, Beijing Hotgen Biotech had annual revenue of 404.88M, down -20.75%.

• Revenue (ttm): 427.66M
• Revenue Growth: -12.17%
• P/S Ratio: 23.65
• Revenue / Employee: n/a
• Employees: 850
• Market Cap: 10.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	404.88M	-106.02M	-20.75%
Dec 31, 2024	510.90M	-36.94M	-6.74%
Dec 31, 2023	547.84M	-3.01B	-84.60%
Dec 31, 2022	3.56B	-1.81B	-33.76%
Dec 31, 2021	5.37B	4.86B	945.54%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 11, 2026

Data Sources Report a data error